These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 35328439)

  • 21. [Migrainous aura subtypes in hospitalized children].
    Biedroń A; Steczkowska M; Zajac A; Stolarska U; Kroczka S
    Przegl Lek; 2009; 66(11):952-7. PubMed ID: 20297637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
    Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
    Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
    Edwards KR; Norton J; Behnke M
    Headache; 2001; 41(10):976-80. PubMed ID: 11903525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of migraine--from molecular to personalized medicine.
    Kojić Z; Stojanović D
    Med Pregl; 2013; 66(1-2):53-7. PubMed ID: 23534301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Migraine: a disorder of brain excitatory-inhibitory balance?
    Vecchia D; Pietrobon D
    Trends Neurosci; 2012 Aug; 35(8):507-20. PubMed ID: 22633369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migraine symptoms: results of a survey of self-reported migraineurs.
    Silberstein SD
    Headache; 1995; 35(7):387-96. PubMed ID: 7672955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migraine and Two-Pore-Domain Potassium Channels.
    Verkest C; Häfner S; Ávalos Prado P; Baron A; Sandoz G
    Neuroscientist; 2021 Jun; 27(3):268-284. PubMed ID: 32715910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migraine: an ophthalmologist's perspective.
    Arunagiri G; Santhi S
    Curr Opin Ophthalmol; 2003 Dec; 14(6):344-52. PubMed ID: 14615638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT
    Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging importance of cortical spreading depression in migraine headache.
    Bolay H; Moskowitz MA
    Rev Neurol (Paris); 2005 Jul; 161(6-7):655-7. PubMed ID: 16141950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
    Munjal S; Singh P; Reed ML; Fanning K; Schwedt TJ; Dodick DW; Buse DC; Lipton RB
    Headache; 2020 Feb; 60(2):416-429. PubMed ID: 31837007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concepts of migraine headache pathogenesis: insights into mechanisms of chronicity and new drug targets.
    Welch KM
    Neurol Sci; 2003 May; 24 Suppl 2():S149-53. PubMed ID: 12811616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Migraine changes with age: IMPACT on migraine classification.
    Kelman L
    Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Migraine pathways and the identification of novel therapeutic targets.
    Rainero I; Roveta F; Vacca A; Noviello C; Rubino E
    Expert Opin Ther Targets; 2020 Mar; 24(3):245-253. PubMed ID: 32054351
    [No Abstract]   [Full Text] [Related]  

  • 36. Aura and Head pain: relationship and gaps in the translational models.
    Bolay H; Vuralli D; Goadsby PJ
    J Headache Pain; 2019 Sep; 20(1):94. PubMed ID: 31481015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin with or without an antiemetic for acute migraine headaches in adults.
    Kirthi V; Derry S; Moore RA; McQuay HJ
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008041. PubMed ID: 20393963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
    Brandes JL; Kudrow D; Yeung PP; Sakai F; Aycardi E; Blankenbiller T; Grozinski-Wolff M; Yang R; Ma Y
    Cephalalgia; 2020 Apr; 40(5):470-477. PubMed ID: 31752521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Migraine variants and beyond.
    Srinivasa R; Kumar R
    J Assoc Physicians India; 2010 Apr; 58 Suppl():14-7. PubMed ID: 21049701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients.
    Chae D; Park K
    J Pharmacokinet Pharmacodyn; 2018 Oct; 45(5):721-731. PubMed ID: 30043250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.